Dr. Rider has invented a number of PANACEA (Pharmacological Augmentation of Nonspecific Anti-pathogen Cellular Enzymes and Activities) broad-spectrum therapeutics and conducted preliminary experiments demonstrating that those approaches are effective in cells and merit further development.
DRACO research is the core focus of the RIDER Institute.
- MIT News – MIT sensor detects pathogens quickly and easily
- NY Times – A better mousetrap is built, detecting deadly bacteria
- MIT Technology Review – Blue Light, Red Light. A new method for detecting deadly pathogens within seconds could become a front-line defense against bioterrorism
- Patent US 6087114 A – Optoelectronic sensor
- Patent US 6800448 B2 – Optoelectronic sensor
- Genome Web – MIT’s ‘CANARY-in-a-Coal-Mine’ Biosensor Tech Shown to Detect Airborne Pathogens
Previously Dr. Rider invented CIGAR (Continual Improvement for Greater Advantage in Rocketry), an improved system of rocket staging that could increase a launch vehicle’s payload capacity by over 50% with no extra propellant. To demonstrate this approach, he wrote orbital flight simulations, tested scale models in a wind tunnel to verify aerodynamic stability of the new design, built small working models to evaluate key mechanical features of the design, and conducted static firing tests.
Dr. Rider has also proposed and explored novel approaches in other areas including biosensors, biofuel cells, DNA synthesizers, and other projects for various sponsors. The RIDER Institute is continuing to develop very innovative approaches to major scientific and technological challenges.